| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.ATV.14.6.869 |
| P698 | PubMed publication ID | 8199176 |
| P2093 | author name string | J D Brunzell | |
| S S Deeb | |||
| D N Nevin | |||
| P433 | issue | 6 | |
| P921 | main subject | familial combined hyperlipidemia | Q2242370 |
| P304 | page(s) | 869-873 | |
| P577 | publication date | 1994-06-01 | |
| P1433 | published in | Arteriosclerosis and thrombosis : a journal of vascular biology | Q27709770 |
| P1476 | title | The LPL gene in individuals with familial combined hyperlipidemia and decreased LPL activity | |
| P478 | volume | 14 |
| Q38331543 | A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity |
| Q34335556 | A mutation in the promoter of the lipoprotein lipase (LPL) gene in a patient with familial combined hyperlipidemia and low LPL activity |
| Q79177405 | A novel mutation, Arg71Thr, in the ?-sarcoglycan gene is associated with dilated cardiomyopathy |
| Q34990615 | Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity |
| Q34107183 | Common mutations of the lipoprotein lipase gene and their clinical significance |
| Q34452376 | Common variation in the lipoprotein lipase gene: effects on plasma lipids and risk of atherosclerosis. |
| Q37364446 | Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes |
| Q35742664 | Deficiency of Lipoprotein Lipase in Neurons Decreases AMPA Receptor Phosphorylation and Leads to Neurobehavioral Abnormalities in Mice |
| Q51566671 | Different regulation of free fatty acid levels and glucose oxidation by the Trp64Arg polymorphism of the beta3-adrenergic receptor gene and the promoter variant (A-3826G) of the uncoupling protein 1 gene in familial combined hyperlipidemia. |
| Q74127774 | Dyslipidemias associated with heterozygous lipoprotein lipase mutations in the French-Canadian population |
| Q50874132 | Gender-related association between the -93T-->G/D9N haplotype of the lipoprotein lipase gene and elevated lipid levels in familial combined hyperlipidemia. |
| Q34107190 | Genetics of familial combined hyperlipidemia |
| Q47933212 | Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis |
| Q24642868 | Investigation of variants identified in caucasian genome-wide association studies for plasma high-density lipoprotein cholesterol and triglycerides levels in Mexican dyslipidemic study samples |
| Q54515187 | New variants in the glycogen synthase gene (Gln71His, Met416Val) in patients with NIDDM from eastern Finland. |
| Q54174859 | Polymorphisms of the human hexokinase II gene: lack of association with NIDDM and insulin resistance. |
| Q35767590 | Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes |
| Q28082905 | Severe/Extreme Hypertriglyceridemia and LDL Apheretic Treatment: Review of the Literature, Original Findings |
| Q37154843 | Small and dense LDL in familial combined hyperlipidemia and N291S polymorphism of the lipoprotein lipase gene. |
| Q41519599 | The acylation stimulating protein pathway: Clinical implications |
| Q52906642 | The cardiac beta-myosin heavy chain gene is not the predominant gene for hypertrophic cardiomyopathy in the Finnish population. |
| Q40964824 | The genetic determinants of plasma cholesterol and response to diet |
| Q37983699 | The genetics of familial combined hyperlipidaemia |
| Q34974691 | The lipoprotein lipase gene in combined hyperlipidemia: evidence of a protective allele depletion |
Search more.